The subsequent gene perturbation experiments in EFAD mouse models further confirmed that LRP10 as a key network regulator of AD in females affected cognitive function and AD-related pathology in sex- and APOE genotype-specific manners. This evidence concerns the gene LRP10 and Alzheimer disease.